Literature DB >> 29902080

Clarifying the confusion between poligeenan, degraded carrageenan, and carrageenan: A review of the chemistry, nomenclature, and in vivo toxicology by the oral route.

James M McKim1, Jamin A Willoughby1, William R Blakemore2, Myra L Weiner3.   

Abstract

Carrageenan (CGN) is a common food additive that has been widely used for decades as a gelling, thickening and stabilizing agent. Carrageenan has been proven safe for human consumption; however, there has been significant confusion in the literature between CGN and the products of intentional acid-hydrolysis of CGN, which are degraded CGN (d-CGN) and poligeenan (PGN). In part, this confusion was due to the nomenclature used in early studies on CGN, where poligeenan was referred to as "degraded carrageenan" (d-CGN) and "degraded carrageenan" was simply referred to as carrageenan. Although this nomenclature has been corrected, confusion still exists resulting in misinterpretation of data and the subsequent dissemination of incorrect information regarding the safe dietary use of CGN. The lack of understanding of the molecular weight distribution of CGN has further exacerbated the issue. The significant differences in chemistry, manufacture, and protein reactivity of CGN versus d-CGN and PGN are reviewed, in addition to the in vivo toxicological profiles of CGN, d-CGN, and PGN. As CGN cannot be hydrolyzed to PGN in vivo, concerns over the use of CGN as a food additive are unfounded, particularly since current studies support the lack of oncogenic and tumorigenic activity of CGN in humans.

Entities:  

Keywords:  Carrageenan; degraded carrageenan; food additive; poligeenan; polydisperse

Mesh:

Substances:

Year:  2018        PMID: 29902080     DOI: 10.1080/10408398.2018.1481822

Source DB:  PubMed          Journal:  Crit Rev Food Sci Nutr        ISSN: 1040-8398            Impact factor:   11.176


  10 in total

1.  Semi-refined carrageenan promotes generation of reactive oxygen species in leukocytes of rats upon oral exposure but not in vitro.

Authors:  Anton S Tkachenko; Yurii G Kot; Valeriy A Kapustnik; Valeriy V Myasoedov; Nataliia I Makieieva; Tetyana O Chumachenko; Anatolii I Onishchenko; Yevgeniya M Lukyanova; Oksana A Nakonechna
Journal:  Wien Med Wochenschr       Date:  2020-10-27

Review 2.  An Overview to the Health Benefits of Seaweeds Consumption.

Authors:  Silvia Lomartire; João Carlos Marques; Ana M M Gonçalves
Journal:  Mar Drugs       Date:  2021-06-15       Impact factor: 5.118

3.  Carrageenans from the Red Seaweed Sarconema filiforme Attenuate Symptoms of Diet-Induced Metabolic Syndrome in Rats.

Authors:  Ryan du Preez; Nicholas Paul; Peter Mouatt; Marwan E Majzoub; Torsten Thomas; Sunil K Panchal; Lindsay Brown
Journal:  Mar Drugs       Date:  2020-01-31       Impact factor: 5.118

4.  Experimental Evaluation of Food-Grade Semi-Refined Carrageenan Toxicity.

Authors:  Denys Pogozhykh; Yevgen Posokhov; Valeriy Myasoedov; Galina Gubina-Vakulyck; Tetyana Chumachenko; Oleksandr Knigavko; Hanna Polikarpova; Yuliia Kalashnyk-Vakulenko; Ketino Sharashydze; Oksana Nakonechna; Volodymyr Prokopyuk; Anatolii Onishchenko; Anton Tkachenko
Journal:  Int J Mol Sci       Date:  2021-10-16       Impact factor: 5.923

Review 5.  Therapeutic activity of fucoidan and carrageenan as marine algal polysaccharides against viruses.

Authors:  Najmeh Oliyaei; Marzieh Moosavi-Nasab; Seyed Mohammad Mazloomi
Journal:  3 Biotech       Date:  2022-06-25       Impact factor: 2.893

6.  In Vitro Toxicity Evaluation of Carrageenan on Cells and Tissues of the Oral Cavity.

Authors:  Babatunde Y Alli; Akshaya Upadhyay; Yuli Zhang; Belinda Nicolau; Simon D Tran
Journal:  Mar Drugs       Date:  2022-08-03       Impact factor: 6.085

7.  Carrageenan-Free Diet Shows Improved Glucose Tolerance and Insulin Signaling in Prediabetes: A Randomized, Pilot Clinical Trial.

Authors:  Leo Feferman; Sumit Bhattacharyya; Erin Oates; Nicole Haggerty; Tianxiu Wang; Krista Varady; Joanne K Tobacman
Journal:  J Diabetes Res       Date:  2020-04-21       Impact factor: 4.011

8.  On the Health Benefits vs. Risks of Seaweeds and Their Constituents: The Curious Case of the Polymer Paradigm.

Authors:  João Cotas; Diana Pacheco; Glacio Souza Araujo; Ana Valado; Alan T Critchley; Leonel Pereira
Journal:  Mar Drugs       Date:  2021-03-19       Impact factor: 5.118

9.  Carrageenan nasal spray may double the rate of recovery from coronavirus and influenza virus infections: Re-analysis of randomized trial data.

Authors:  Harri Hemilä; Elizabeth Chalker
Journal:  Pharmacol Res Perspect       Date:  2021-08

Review 10.  Seaweed Components as Potential Modulators of the Gut Microbiota.

Authors:  Emer Shannon; Michael Conlon; Maria Hayes
Journal:  Mar Drugs       Date:  2021-06-23       Impact factor: 5.118

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.